GMP transition support for viral vector manufacture
Lead Participant:
CELL THERAPY CATAPULT LIMITED
Abstract
Awaiting Public Project Summary
Lead Participant | Project Cost | Grant Offer |
---|---|---|
CELL THERAPY CATAPULT LIMITED | £361,220 | £ 361,220 |
  | ||
Participant |
||
THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST |
People |
ORCID iD |
Emma Kinsey (Project Manager) |